Effect of prenatal exposure to ethanol on hepatic elongation factor-2 and proteome in 21 d old rats: Protective effect of folic acid

Free Radical Biology and Medicine

Volumn 35, Issue 4, 2003, Pages 428-437

  Garcia Rodriguez S ^a   Arguelles S ^a   Llopis, R ^a   Murillo, M L ^a   Machado, A ^a   Carreras, O ^a   Ayala, Antonio ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Elongation factor 2; ER 60 protease; Ethanol; Gelsolin; Protein synthesis; Proteome; RhoGDI 1

Indexed keywords

ALCOHOL; ELONGATION FACTOR 2; ER 60 PROTEINASE; FOLIC ACID; GELSOLIN; LIVER PROTEIN; PROTEIN RHOGDI 1; PROTEINASE; PROTEOME; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LACTATION; LIVER; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATION; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEOMICS; UTERUS; VITAMIN SUPPLEMENTATION;

EID: 17144439283     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00321-6     Document Type: Article

References (71)

1. Jones K.L., Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 2:1973;999-1001.
2. Mattson S.N., Schoenfeld A.M., Riley E.P. Teratogenic effects of alcohol on brain and behaviour. Alcohol Res. Health. 25:2001;185-191.
3. Goodlett C.R., Horn K.H. Mechanisms of alcohol-induced damage to the developing nervous system. Alcohol Res. Health. 25:2001;175-184.
4. Berman R.F., Hannigan J.H. Effects of prenatal alcohol exposure on the hippocampus spatial behaviour, electrophysiology, and neuroanatomy . Hippocampus. 10:2000;94-110.
5. Barr H.M., Streissguth A.P. Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders. Alcohol Clin. Exp. Res. 25:2001;283-287.
6. Warren K.R., Foudin L.L. Alcohol-related birth defects - the past, present, and future. Alcohol Res. Health. 25:2001;153-158.
7. May P.A., Gossage J.P. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res. Health. 25:2001;159-167.
8. Bagheri M.M., Burd L., Martsolf J.T., Klug M.G. Fetal alcohol syndrome maternal and neonatal characteristics . J. Perinat. Med. 26:1998;263-269.
9. Murillo-Fuentes L., Artillo R., Carreras O., Murillo M.L. Effects of maternal chronic alcohol administration in the rat lactation performance and pup's growth . Eur. J. Nutr. 40:2001;147-154.
10. Adachi M., Ishii H. Role of mitochondria in alcoholic liver injury. Free Radic. Biol. Med. 32:2002;487-491.
11. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 32:2002;110-114.
12. Goodlett C.R., Horn K.H. Mechanisms of alcohol-induced damage to the developing nervous system. Alcohol Res. Health. 25:2001;175-184.
13. Lieber C.S. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver disease. Adv. Pharmacol. 38:1997;601-628.
14. Stewart S., Jones D., Day C.P. Alcoholic disease new insights into mechanisms and preventative strategies . Trends Mol. Med. 7:2001;408-413.
15. Hoek J.B., Cahill A., Pastorino J.G. Alcohol and mitochondria a dysfunctional relationship . Gastroenterology. 122:2002;2049-2063.
16. Ramachandran V., Perez A., Chen J., Senthil D., Schenker S., Henderson G.I. In utero ethanol exposure causes mitochondria dysfunction, which can result in apoptotic cell death in fetal brain a potential role for 4-hydroxynonenal . Alcohol Clin. Exp. Res. 25:2001;862-871.
17. Cano M.J., Ayala A., Murillo M.L., Carreras O. Protective effect of folic acid against oxidative stress produced in 21-days postpartum rats by maternal-ethanol chronic consumption during pregnancy and lactation period. Free Radic. Res. 34:2001;1-8.
18. Henderson G.I., Chen J.J., Schenker S. Ethanol, oxidative stress, reactive aldehydes, and the fetus. Front. Biosci. 4:1999;D541-D550.
19. Amini S.A., Dunstan R.H., Dunkley P.R., Murdoch R.N. Oxidative stress and the fetotoxicity of alcohol consumption during pregnancy. Free Radic. Biol. Med. 21:1996;357-365.
20. Ryazanov A.G., Nefsky B.S. Protein turnover plays a key role in aging. Mech. Ageing Dev. 123:2002;207-213.
21. Richardson A., Birchenall-Sparks M.C. Age-related changes in protein synthesis. Rothstein M.R. Review of biological research in aging, Vol. 1. 1983;255-273 Alan R. Liss, Inc, New York.
22. Makrides S.C. Protein synthesis and degradation during aging and senescence. Biol. Rev. Camb. Philos. Soc. 58:1983;343-422.
23. Webster G.C. Protein synthesis in aging organisms. Sohal R.S., Birnbaum L.S., Cutler R.G. Molecular biology of aging gene stability and gene expression . 1985;263-269 Raven Press, New York.
24. Rattan S.I., Clark B.F. Intracellular protein synthesis, modifications and aging. Biochem. Soc. Trans. 24:1996;1043-1049.
25. Rattan S.I. Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31:1996;33-47.
26. Ayala A., Parrado J., Bougria M., Machado A. Effect of oxidative stress, produced by cumene hydroperoxide, on the various steps of protein synthesis. J. Biol. Chem. 271:1996;23105-23110.
27. Parrado J., Bougria M., Ayala A., Castaño A., Machado A. Effects of aging on the various steps of protein synthesis fragmentation of elongation factor 2. Free Radic. Biol. Med. 26:1999;362-370.
28. Kim Y.I. Folate and cancer prevention a new medical application of folate beyond hyperhomocysteinemia and neural tube defects . Nutr. Rev. 57:1999;314-321.
29. Sellers T.A., Kushi L.H., Cerham J.R., Vierkant R.A., Gapstur S.M., Vachon C.M., Olson J.E., Therneau T.M., Folsom A.R. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 12:2001;420-428.
30. Tavares E., Gómez-Tubio A., Murillo M.L., Carreras O. Folic acid intestinal absorption in newborn rats at 21 day post-partum effect of maternal consumption . Life Sci. 64:1999;2001-2010.
31. Control of diets in laboratory animals experimentation. Nutr. Abstr. Rev. 49:1979;413-419.
32. Lowry O.H., Rosebrough N.J., Farr A.L. Randall, R .J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
33. Bailey S.M., Patel V.B., Young T.A., Asayama K., Cunninghan C.C. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver. Alcohol Clin. Exp. Res. 25:2001;726-733.
34. Rouach H., Fataccioli V., Gentil M., French S.W., Morimoto M., Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology. 25:1997;351-355.
35. Clot P., Tabone M., Arico S., Albano E. Monitoring oxidative damage in patients with liver cirrosis and different daily alcohol intake. Gut. 35:1994;1637-1643.
36. Collins A.R. Alcohol and DNA damage. J. Lab. Clin Med. 136:2000;258-259.
37. Brooks P.J. DNA damage, DNA repair, and alcohol toxicity - a review. Alcohol Clin. Exp. Res. 21:1997;1073-1082.
38. Muresan C., Eremia I. Ethanol stimulates the formation of free oxygen radicals in the brain of newborn rats. Rom. J. Morphol. Embryol. 43:1997;113-117.
39. Chen J.J., Petersen D.R., Schenker S., Henderson G.I. Formation of malondialdehyde adducts in livers of rats exposed to ethanol role in ethanol-mediated inhibition of cytochrome c oxidase . Alcohol Clin. Exp. Res. 24:2000;544-552.
40. Devi B.G., Schenker S., Mazloum B., Henderson G.I. Ethanol-induced oxidative stress and enzymatic defenses in cultured fetal rat hepatocytes. Alcohol. 13:1996;327-332.
41. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., Wong L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 285:2001;2981-2986.
42. McNulty H., Cuskelly G.J., Ward M. Response of red blood cell folate to intervention implications for folate recommendations for the prevention of neural tube defects . Am. J. Clin. Nutr. 71:2000;1308S-1311S.
43. Joshi R., Adhikari S., Patro B.S., Chattopadhyay S., Mukherjee T. Free radical scavenging behaviour of folic acid evidence for possible antioxidant activity . Free Radic. Biol. Med. 30:2001;1390-1399.
44. Lucock M. Folic acid nutritional biochemistry, molecular biology, and role in disease processes . Mol. Genet. Metab. 71:2000;121-138.
45. Kim Y.I. Folate and cancer prevention a new medical application of folate beyond hyperhomocysteinemia and neural tube defects . Nutr. Rev. 57:1999;314-321.
46. Tapiero H., Tew K.D., Gate L., Machover D. Prevention of pathologies associated with oxidative stress and dietary intake deficiencies folate deficiency and requirements . Biomed. Pharmacother. 55:2001;381-390.
47. Ames, B. N. Micronutrients prevent cancer and delay aging. Toxicol. Lett. 102-103:5-18; 1998.
48. Choi S.W., Mason J.B. Folate status effects on pathways of colorectal carcinogenesis . J. Nutr. 132:2002;2413S-2418S.
49. Sohal R.S. Role of oxidative stress and protein oxidation in the aging process. Free Radic. Biol. Med. 33:2002;37-44.
50. Patel V.B., Cunningham C.C. Altered hepatic mitochondrial ribosome structure following chronic ethanol consumption. Arch. Biochem. Biophys. 398:2002;41-50.
51. Cahill A., Cunningham C.C. Effects of chronic ethanol feeding on the protein composition of mitochondrial ribosomes. Electrophoresis. 21:2000;3420-3426.
52. Berlett B.S., Stadtman E.R. Protein oxidation in aging disease, and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
53. Flint B. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32:2002;797-803.
54. Uchida K., Kato Y., Kawakishi S. A novel mechanism for oxidative cleavage of prolyl peptides induced by the hydroxyl radical. Biochem. Biophys. Res. Commun. 169:1990;265-271.
55. Bota D.A., Davies K.J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 4:2002;674-680.
56. Shringarpure R., Davies K.J. Protein turnover by the proteasome in aging and disease. Free Radic. Biol. Med. 32:2002;1084-1089.
57. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 83:2001;301-310.
58. Stadtman E.R. Protein oxidation in aging and age-related diseases. Ann. NY Acad. Sci. 928:2001;22-38.
59. Levine R.L., Stadtman E.R. Oxidative modification of proteins during aging. Exp. Gerontol. 36:2001;1495-1502.
60. Stadtman E.R., Levine R.L. Protein oxidation. Ann. NY Acad. Sci. 899:2000;191-208.
61. Stadtman E.R. Role of oxidized amino acids in protein breakdown and stability. Methods Enzymol. 258:1995;379-393.
62. Symons M., Settleman J. Rho family GTPases more than simple switches . Trends Cell Biol. 10:2000;415-419.
63. Olofsson B. Rho guanine dissociation inhibitors pivotal molecules in cellular signaling . Cell. Signal. 11:1999;545-554.
64. Radcliffe C.M., Diedrich G., Harvey D.J., Dwek R.A., Cresswell P., Rudd P.M. Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J. Biol. Chem. 277:2002;46415-46423.
65. Antoniou A.N., Ford S., Alphey M., Osborne A., Elliot T., Powis S.J. The oxidoreductase Erp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules. EMBO J. 21:2002;2655-2663.
66. Ellgaard L., Helenius A. ER quality control towards an understanding at the molecular level . Curr. Opin. Cell. Biol. 13:2001;431-437.
67. Morrice N.A., Powis S.J. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr. Biol. 8:1998;713-716.
68. Oliver J.D., Roderick H.L., Llewellyn D.H., High S. ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. Mol. Biol. Cell. 10:1999;2573-2582.
69. McGough A. F-actin binding proteins. Curr. Opin. Struct. Biol. 8:1998;166-176.
70. McGrath J.L., Osborn E.A., Tardy Y.S., Dewey C.F. Jr., Hartwig J.H. Regulation of the actin cycle in vivo by actin filament severing. Proc. Natl. Acad. Sci. USA. 97:2000;6532-6537.
71. Dahl B., Schiodt F.V., Ott P., Gvozdenovic R., Yin H.L., Lee W.M. Plasma gelsolin is reduced in trauma patients. Shock. 12:1999;102-104.